Clinical Trial Update: A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers [Phase 1]

View source ↗

Summary

Phase 1 update reporting the taste assessment of different oral liquid preparations of CP-690,550 (tofacitinib) in trained adult testers; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CP-690,550 (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED